TL;DR
This paper introduces a novel dual-crosslinked hydrogel made from Gelatin Methacryloyl (GelMA) and Sulfhydrylated Chitosan (CS-SH) for advanced wound healing. This hydrogel exhibits enhanced mechanical strength, moisture retention, and antibacterial properties, leading to significantly accelerated full-thickness wound closure in rat models.
What Problem Does This Paper Address?
Full-thickness skin injuries, such as deep wounds, pose a significant challenge in clinical practice due to their slow healing rates and increased risk of infection. Traditional wound dressings often lack the necessary therapeutic properties to actively promote healing. While natural polymers like chitosan and gelatin are promising for wound dressings, they have limitations: chitosan requires acidic conditions for dissolution, and gelatin alone has poor mechanical strength and no inherent antibacterial activity. This research aims to overcome these limitations by developing a composite hydrogel that combines the benefits of both materials, offering improved mechanical properties, biocompatibility, and therapeutic effects for effective wound healing.
Methods
The researchers developed a dual-crosslinking strategy to create the GelMA/CS-SH hydrogel (GCH). First, sulfhydrylated chitosan (CS-SH) was synthesized by grafting 2-iminothiolane onto chitosan. Then, photocrosslinkable GelMA was combined with CS-SH. The dual crosslinking occurred through two mechanisms: light-induced polymerization of GelMA's vinyl groups and a Thiol-ene reaction between GelMA's vinyl groups and CS-SH's sulfhydryl groups. This resulted in a robust hydrogel network.
Key characterization techniques included:
- NMR and FTIR spectroscopy: To confirm the chemical structures of GelMA and CS-SH and the successful synthesis.
- SEM: To visualize the porous internal structure of the hydrogels.
- Compression testing: To evaluate the mechanical properties, specifically the compressive modulus.
- Swelling and water retention tests: To assess the hydrogel's ability to maintain a moist wound environment.
- In vitro biocompatibility assays: Live/dead staining and CCK-8 assays were used to assess the cytotoxicity and proliferation of adipose-derived stromal cells (ASCs). Tube formation assays with human umbilical vein endothelial cells (HUVECs) were performed to evaluate angiogenic potential.
- Antibacterial testing: E. coli was co-cultured with the hydrogels to assess their ability to inhibit bacterial growth.
- In vivo wound healing studies: Full-thickness skin defects were created on rats, and the GCH hydrogel was applied to one group, with the other serving as a control. Wound healing progress was monitored macroscopically and histologically.
- Histological analysis: Hematoxylin-eosin (H&E) staining, Masson trichrome staining, and immunohistochemical (IHC) staining for CD31 (angiogenesis marker) and VEGFR (vascular endothelial growth factor receptor) were performed to evaluate tissue regeneration, inflammation, blood vessel formation, and collagen deposition.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Synergistic Dual Crosslinking: The combination of photocrosslinking (GelMA) and Thiol-ene click chemistry (GelMA-CS-SH) creates a significantly stronger and more stable hydrogel network than either crosslinking method alone. This dual approach is key to achieving enhanced mechanical properties.
- Tunable Mechanical Strength: The compressive modulus of the GCH hydrogel can be effectively tuned by adjusting the concentration of CS-SH, allowing for customization based on specific wound healing needs.
- Chitosan's Multifaceted Role: CS-SH not only contributes to the mechanical strength and stability but also imparts crucial antibacterial properties, addressing a common limitation of other wound dressing materials.
- Promoting Angiogenesis: The GCH hydrogel actively promotes blood vessel formation, evidenced by increased CD31 and VEGFR expression, which is vital for delivering oxygen and nutrients to the wound site and facilitating tissue regeneration.
- Accelerated and Orderly Healing: In vivo studies demonstrate that the GCH hydrogel significantly accelerates the healing of full-thickness skin defects, leading to more organized collagen deposition and faster repair of skin structures like hair follicles.
Key Results
- Mechanical Properties: The compressive modulus of the GCH hydrogel reached up to ~40 kPa, significantly higher than pure GelMA hydrogel (~2 kPa). This modulus increased with higher CS-SH content.
- In Vitro Biocompatibility: GCH showed no significant cytotoxicity to ASCs, and even promoted cell proliferation at higher CS-SH concentrations. It also supported angiogenesis in vitro.
- Antibacterial Activity: The GCH hydrogel, particularly at higher CS-SH concentrations, effectively inhibited the growth of E. coli, demonstrating its antibacterial efficacy.
- In Vivo Wound Healing: Full-thickness skin defects in rats treated with GCH healed completely by day 15, showing significantly faster closure compared to the untreated control group. Histological analysis revealed reduced inflammation, accelerated hair follicle repair, and more orderly collagen fiber growth in the GCH group.
- Angiogenesis: GCH treatment led to increased blood vessel formation (higher CD31 staining) and enhanced VEGFR expression, indicating improved vascularization of the wound site.
Limitations and Future Work
- Murine Wound Healing Model: The authors note that murine wound healing can occur via contraction rather than re-epithelialization, suggesting that future studies could benefit from splinted murine wounds to better investigate re-epithelialization.
- Hif-1 Expression: While IHC staining for Hif-1 was performed, both groups showed negative results, which the authors attribute to the wound being exposed to air. They suggest this indicates the hydrogel provides a porous structure to prevent hypoxia. However, further investigation into Hif-1's role in this specific context might be warranted.
- Long-term Scarring: While the study shows improved collagen organization, long-term assessment of scar formation and cosmetic outcomes could be a valuable future direction.
- Clinical Translation: The study was conducted in a rat model. Further preclinical and clinical trials would be necessary to confirm the efficacy and safety of this hydrogel for human wound healing applications.
Summary updated